ArticleChemMedChem2022

Targeted Enzymatic VLP-Nanoreactors with β-Glucocerebrosidase Activity as Potential Enzyme Replacement Therapy for Gaucher's Disease.

Kanchan Chauhan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.